Skip to main content
. 2023 Dec 15;19(9):1890–1898. doi: 10.4103/1673-5374.390964

Figure 2.

Figure 2

The structures of inhibitors that target the NLRP3 inflammasome pathway for the treatment of depression.

The structures were obtained from https://pubchem.ncbi.nlm.nih.gov/ (Kim et al., 2023). (A) BAY 117082; (B) beta-hydroxybutyrate; (C) A438079; (D) MCC950; (E) Cli-095; (F) CY-09; (G) Brilliant Blue G; (H) VX765.